Table 2.
Hormone | WT, SO (n = 9) | WT, Untreated (n = 6) | Kiss1−/− E2/Gonadotropin-Primed/SO (n = 6) | Kiss1−/− Untreated (n = 4) | Kiss1−/− E2/Gonadotropin-Primed/SO+P4 (Day 3) +E2 (Day 4) (n = 5) |
---|---|---|---|---|---|
P4, ng/mL | 109.0 ± 23.7 | 43.5 ± 10.1 | 44.3 ± 10.3 | 7.1 ± 0.6 | 83.1 ± 7.9 |
Abbreviation: SO, superovulated. Groups are as follows: 1) SO WT females; 2) untreated WT females; 3) E2/gonadotropin-primed SO Kiss1−/− females; 4) untreated Kiss1−/− females; and 5) E2/gonadotropin-primed SO Kiss1−/− females that received a P4 injection (sc) (1 mg/100 μL) on the third day after mating followed by an E2 injection (sc) (20 ng/100 μL) on the morning of day 4. Data are shown as mean ± SEM.